转录因子
增强子
抄写(语言学)
生物
发起人
癌症研究
一般转录因子
RNA聚合酶Ⅱ
关贸总协定
癌症
电箱
响应元素
生物信息学
基因
基因表达
遗传学
语言学
哲学
作者
Yiwei Li,Asfar S. Azmi,Ramzi M. Mohammad
标识
DOI:10.1016/j.semcancer.2022.08.001
摘要
Transcription factors are a group of proteins, which possess DNA-binding domains, bind to DNA strands of promoters or enhancers, and initiate transcription of genes with cooperation of RNA polymerase and other co-factors. They play crucial roles in regulating transcription during embryogenesis and development. Their physiological status in different cell types is also important to maintain cellular homeostasis. Therefore, any deregulation of transcription factors will lead to the development of cancer cells and tumor progression. Based on their functions in cancer cells, transcription factors could be either oncogenic or tumor suppressive. Furthermore, transcription factors have been shown to modulate cancer stem cells, epithelial-mesenchymal transition (EMT) and drug response; therefore, measuring deregulated transcription factors is hypothesized to predict treatment outcomes of patients with cancers and targeting deregulated transcription factors could be an encouraging strategy for cancer therapy. Here, we summarize the current knowledge of major deregulated transcription factors and their effects on causing poor clinical outcome of patients with cancer. The information presented here will help to predict the prognosis and drug response and to design novel drugs and therapeutic strategies for the treatment of cancers by targeting deregulated transcription factors.
科研通智能强力驱动
Strongly Powered by AbleSci AI